Caribou Biosciences, Inc. (CRBU) Tops Q3 EPS by 30c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. CVS

Go back to Caribou Biosciences, Inc. (CRBU) Tops Q3 EPS by 30c

Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update

November 7, 2023 4:00 PM EST

-- CB-010 ANTLER Phase 1 trial continues enrolling second-line r/r LBCL patients in dose expansion; plan to share FDA feedback by year-end 2023 and report initial dose expansion data in H1 2024 --

-- CB-011 CaMMouflage Phase 1 trial enrollment ongoing in r/r MM patients --

-- CB-012 AMpLify Phase 1 trial site activation underway following recent IND clearance; expect to initiate enrollment by mid-2024 in r/r AML patients --

-- $396.7 million in cash, cash equivalents, and marketable securities expected to fund the current operating... More